Table: Kaken Pharmaceutical -6-MTH group results

KAKEN PHARMACEUTICAL

07/11/2016 04:30

Nov 7 (Reuters)-  
             Kaken Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2016        Sep 30, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             52.18               54.97           106.10     
                 (-5.1 pct)          (+24.3 pct)      (-3.3 pct)   
  Operating         16.12               18.44            28.90     
                 (-12.6 pct)        (+109.4 pct)      (-17.8 pct)  
  Recurring         16.24               18.57            29.10     
                 (-12.6 pct)        (+114.1 pct)      (-17.7 pct)  
  Net               11.45               12.48            20.80     
                 (-8.3 pct)         (+121.4 pct)      (-1.6 pct)   
  EPS            278.02 yen          301.39 yen       508.90 yen   
  Ann Div                                             150.00 yen   
  -Q2 div         75.00 yen           34.00 yen                    
  -Q4 div                             78.00 yen        75.00 yen   
   
  NOTE - Kaken Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T  
  ((Tokyo Headline News Desk +813 6441 1812))